Evidence map›Paper›PMID 36091007›Full record

ArticleFrontiers in immunology2022

Distinct plasma chemokines and cytokines signatures in

Tirza Gabrielle Ramos de Mesquita, José do Espírito Santo Junior, Luan Diego Oliveira da Silva, George Allan Villarouco Silva, Felipe Jules de Araújo, Suzana Kanawati Pinheiro, Herllon Karllos Athaydes Kerr, Lener Santos da Silva, Luciane Macedo de Souza, Samir Assad de Almeida and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Tirza Gabrielle Ramos de MesquitaPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
José do Espírito Santo JuniorPrograma de Pós-Graduação em Imunologia Básica e Aplicada, Instituto de Ciências Biológicas, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Luan Diego Oliveira da SilvaFaculdade de Medicina Nilton Lins, Universidade Nilton Lins, Manaus, Brazil.
George Allan Villarouco SilvaPrograma de Pós-Graduação em Imunologia Básica e Aplicada, Instituto de Ciências Biológicas, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Felipe Jules de AraújoPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Suzana Kanawati PinheiroPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Herllon Karllos Athaydes KerrPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Lener Santos da SilvaPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Luciane Macedo de SouzaPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Samir Assad de AlmeidaFaculdade de Medicina Nilton Lins, Universidade Nilton Lins, Manaus, Brazil.
Krys Layane Guimarães Duarte QueirozDepartment of Molecular Biology, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil.
Josué Lacerda de SouzaPrograma de Pós-Graduação em Imunologia Básica e Aplicada, Instituto de Ciências Biológicas, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Cilana Chagas da SilvaDepartment of Molecular Biology, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil.
Héctor David Graterol SequeraPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Mara Lúcia Gomes de SouzaPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Anderson Nogueira BarbosaDepartment of Virology, Instituto Nacional de Pesquisas da Amazônia, Manaus, Brazil.
Gemilson Soares PontesPrograma de Pós-Graduação em Imunologia Básica e Aplicada, Instituto de Ciências Biológicas, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Marcus Vinitius de Farias GuerraPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Rajendranath RamasawmyPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Universidade do Estado do Amazonas · BRUniversidade Federal do Amazonas · BRFundação de Medicina Tropical · BRUniversidade Nilton Lins · BRNational Institute of Amazonian Research · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immunopathology associated with Leishmaniasis is a consequence of inflammation. Upon infection with

Indexed as

Leishmania guyanensisLeishmaniasis, CutaneousBiomarkersChemokine CCL4Chemokine CCL5Chemokine CXCL10CytokinesHumansInterleukin-12Interleukin-17Interleukin 1 Receptor Antagonist ProteinInterleukin-2Interleukin-6Interleukin-9BiomarkersChemokine CCL4Chemokine CCL5Chemokine CXCL10CytokinesInterleukin-12Interleukin-17Interleukin 1 Receptor Antagonist ProteinInterleukin-2Interleukin-6Interleukin-9chemokinescutaneous leishmaniasiscytokinesgrowth factorsLeishmania guyanensis

Identifiers

PMID36091007
PMCPMC9453042
OpenAlexW4293230725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.